Salivary transcriptomic and proteomic biomarkers for breast cancer detection
US9624547B2 · kind B2 · utility
1Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 10, 2011 |
| Grant date | Apr 18, 2017 |
| Priority date | — |
| Expiry date | Feb 10, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Presented herein are biomarkers related to breast cancer. The presently identified salivary biomarkers create the basis for a breast cancer detection bioassay with sensitivity and specificity. Means and methods for evaluating the data generated using multiple biomarkers in order to validate findings and further use of the multiplexed breast cancer assay in clinical, diagnostic and therapeutic uses is also included.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.